Targeting Venetoclax Resistant CLL Using a Protac-Based BCL-2/BCL-XL Degrader

Autor: Diaz Rohena, Daisy *, Slawin, Bailey *, Ravikrishnan, Janani, Liu, Chaomei *, Hu, Wanyi *, Zhang, Peiyi *, Thompson, Philip A., Wierda, William G., Jain, Nitin, Zheng, Guangrong *, Zhou, Daohong, Woyach, Jennifer A., Sampath, Deepa
Zdroj: In Blood 15 November 2022 140 Supplement 1:497-498
Databáze: ScienceDirect